GPRC6A and fatty liver disease: Similarly, GPRC6A−/− mice had elevated serum glucose levels (Table 1) glucose intolerance, insulin resistance and hepatic steatosis, as evidence by histological presence of fat and biochemical evidence of increase triglyceride content in livers of knockout mice (Fig. 5).